Post-Market SafetyDetect the signal before
Detect the signal before
the spontaneous report.
94% of adverse drug reactions go undetected by current reporting systems. Frekil runs active surveillance across millions of patient records so you don't have to wait for someone to file a report.
Active Surveillance LogScanning...
Risk Threshold
Signal Detected
Elevated incidence rate in Cohort B
Signal Detection
Continuously scan EHR and claims data for statistically significant adverse event correlations before they become crises.
Post-Market Studies
Execute Post-Authorization Safety and Efficacy Studies with automated, reproducible code.
Active Surveillance
Shift from passive spontaneous reporting (FAERS) to active, longitudinal tracking of exposed patient cohorts.
Risk Minimization
Quantify the real-world impact of risk mitigation strategies dynamically across patient populations.
Safety monitoring shouldn't be a manual process.
Frekil generates transparent, reproducible statistical outputs for post-market safety commitments — ready for any stakeholder review.